| Back to Autism Information >> Next Topic | ||
I also posted this under oral chelation since it also mentioned it. One study will define differences — both biological and behavioral — in autistic children with diverse developmental histories. In another study, NIMH researchers will examine the use of the antibiotic minocycline to measure its usefulness in treating regressive autism. Past research suggests that autism may be linked to changes in the immune response that cause inflammation in the brain.
A third study addresses the widespread but unproven theory that autism may be treated successfully by chelation therapy, which seeks to remove heavy metals from the blood. Chelation is more commonly used to treat lead toxicity, but many families seek the treatment to try to remove mercury and other metals from their autistic children's blood. This practice is based on the belief that many cases of autism were caused by exposure to thimerosol, a mercury-based preservative previously used in childhood vaccines.
This is the link about the chelation clinical trial: http://www.clinicaltrials.gov/ct/show/NCT00376194?order=40
If you want to look at other clinical trials, you can click here:http://www.clinicaltrials.gov/ct/screen/BrowseAny?path=%2Fbr owse%2Fby-condition%2Faz%2FA%2FD001321%2BAutistic%2BDisorder &recruiting=false |
||
|
Copyright Autism-PDD.net
|